Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.

  1. News


Accelerating new rare disease therapies through collaboration agreement

Global award honors entrepreneurship, innovation, and personal commitment

Supporting rare disease diagnosis, education, and clinical research

Driving Accelerated Diagnosis and Treatment Development

Driving personalized, immune-based therapy to target patients’ own immune responses

CENTOGENE biomarker measures lyso-Gb1 levels in children

Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database

Artificial Intelligence verbessert die Diagnose seltener Erkrankungen, basierend auf der weltweit größten kuratierten...

Research findings may provide deeper understanding on the role of genes that can contribute to development of...

In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program.